| Announce Date | 12/01/2025 |
| EPS Normalized Actual | $0.67 (Beat by $0.1782) |
| EPS GAAP Actual | $0.67 (Beat by $0.1782) |
| Revenue Actual | $0.268027B |
| Revenue Surprise | Beat by $268.027M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Apr 2030 | 4.85 | 27.78 | 4.56994 | 5.32186 | 1 |
| May 2029 | 2.56 | 52.63 | 2.24319 | 2.78579 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 0.47 | 0.47 | 0.268027B | 73.12% | 268.03M |
| FQ3 2025 (Aug 2025) | 0.37 | 0.37 | 0.223074B | 73.23% | 223.07M |
| FQ2 2025 (May 2025) | 0.21 | 0.21 | 0.170025B | 64.25% | 170.03M |
| FQ1 2025 (Feb 2025) | 0.17 | 0.17 | 0.135002B | 60.7% | 135M |
| FQ4 2024 (Nov 2024) | -0.0254 | -0.0254 | 0.072034B | 38.87% | 72.03M |
| FQ3 2024 (Aug 2024) | -0.0578 | -0.0578 | 0.059714B | 41.23% | 59.71M |
| FQ3 2020 (Jul 2020) | -0.0666 | -0.0666 | 0.011038B | 100% | 11.04M |
| FQ4 2020 (Oct 2020) | -0.21 | -0.21 | 0.014451B | 100% | 14.45M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2028 (May 2028) | 1.17458 | -- | 1.15733 | 1.21946 | 5 |
| FQ1 2028 (Feb 2028) | 1.13396 | -- | 1.1173 | 1.17729 | 4 |
| FQ4 2027 (Nov 2027) | 1.0808 | -- | 1.06493 | 1.1221 | 4 |
| FQ3 2027 (Aug 2027) | 1.02462 | -- | 1.00957 | 1.06377 | 3 |
| FQ2 2027 (Apr 2027) | 0.26 | -- | 0.24816 | 0.27287 | 3 |
| FQ1 2027 (Feb 2027) | 0.34363 | -- | 0.33835 | 0.34877 | 4 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2028 (May 2028) | 0.54B | -- | 0.54B | 0.56B | 2 |
| FQ1 2028 (Feb 2028) | 0.52B | -- | 0.51B | 0.53B | 3 |
| FQ4 2027 (Nov 2027) | 0.5B | -- | 0.49B | 0.51B | 4 |
| FQ3 2027 (Aug 2027) | 0.47B | -- | 0.47B | 0.48B | 5 |
| FQ2 2027 (Apr 2027) | 0.15B | -- | 0.15B | 0.16B | 4 |
| FQ1 2027 (Feb 2027) | 0.2B | -- | 0.19B | 0.2B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
4
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 0.47 | 0.47 | 100% | |
| FQ3 2025 (Aug 2025) | 0.37 | 0.37 | 100% | |
| FQ2 2025 (May 2025) | 0.21 | 0.21 | 100% | |
| FQ1 2025 (Feb 2025) | 0.17 | 0.17 | 100% | |
| FQ4 2024 (Nov 2024) | -0.0254 | -0.0254 | 100% | |
| FQ3 2024 (Aug 2024) | -0.0578 | -0.0578 | 100% | |
| FQ3 2020 (Jul 2020) | -0.0666 | -0.0666 | 100% | |
| FQ4 2020 (Oct 2020) | -0.21 | -0.21 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | $0B | $0.27B | $268.03M | 100% |
| FQ3 2025 (Aug 2025) | $0B | $0.22B | $223.07M | 100% |
| FQ2 2025 (May 2025) | $0B | $0.17B | $170.03M | 100% |
| FQ1 2025 (Feb 2025) | $0B | $0.14B | $135M | 100% |
| FQ4 2024 (Nov 2024) | $0B | $0.07B | $72.03M | 100% |
| FQ3 2024 (Aug 2024) | $0B | $0.06B | $59.71M | 100% |
| FQ3 2020 (Jul 2020) | $0B | $0.01B | $11.04M | 100% |
| FQ4 2020 (Oct 2020) | $0B | $0.01B | $14.45M | 100% |